Search

everythinglearnresearchcommunity

for

Search:↓

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

Both treatments for alopecia areata are equally effective and safe.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

The patch effectively promotes hair growth for alopecia areata without pain.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Oral Apremilast effectively treats alopecia areata in most patients.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

AMT® shows promise as a safe and effective treatment for early-stage knee osteoarthritis.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

A group has developed therapies that show promise for treating cancer and various other conditions.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Candida antigen is an effective and promising treatment for alopecia areata.

Beard alopecia areata causes patchy beard hair loss, often treatable with janus kinase inhibitors.

Combining triamcinolone acetonide with cryotherapy may reduce scalp hair loss more than using triamcinolone alone.

Patients with alopecia areata might have a lower risk of stroke and possibly heart attack.

The new treatment showed promise in managing eyebrow hair loss.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Both cryotherapy and FCO2 laser are effective and safe for treating patchy alopecia areata.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.